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Abstract
Non-alcoholic fatty liver disease (NAFLD) is a condition where the content of 
intrahepatic triglycerides (steatosis) rises, inclusive or exclusive of inflammation 
and fibrosis (namely steatohepatitis). It is acknowledged all over the world as 
the leading cause of chronic liver disease (CLD). Mulberry, a phytonutrient-rich 
plant belongs to the genus Morus, has been widely used as one of the conventional 
medicinal plants due to its chemical composition and pharmacological utility. 
Identification of leaf extract (M. latifolia) revealed chlorogenic acid, rutin, quer-
cetin, caffeic acid and coumaric acid as functional bioactive principles. Objective 
of the current study was to evaluate the beneficial effect of M. latifolia in treating 
HFCS-induced metabolic disorders, namely, dyslipidaemia and non-alcoholic 
fatty liver disease (NAFLD), in rat models. Study determined body weight, 
blood glucose, lipid profile, liver marker enzymes and histopathology of liver 
tissues. Study concluded that administration of M. latifolia leaf extract showed a 
significant decrease in body weight and the levels of lipid profile, blood glucose 
and liver marker enzymes in HFCS-induced rats compared to HFCS control rats. 
Histopathological studies confirmed the antihyperlipidaemic properties of M. 
latifolia leaf extract in reducing the hepatic fat accumulation causing regeneration 
of liver tissues in HFCS-fed rats.
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1. Introduction
Obesity has become a major public health problem worldwide and is of crucial 
concern in the field of preventive medicine. It is a medical condition where exces-
sive lipid is accumulated in the body, which results in increased adipose tissue 
mass and dysregulation of lipid metabolism. The prevalence of obesity has rapidly 
increased in the past few decades due to changes in lifestyle factors, especially diet 
[1]. Obesity is closely associated with diseases such as non-alcoholic fatty liver 
disease (NAFLD), hypertension, hyperlipidaemia, arteriosclerosis and cancer [1–3].
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Non-alcoholic fatty liver disease (NAFLD) results in a rise in content of intra-
hepatic triglyceride (IHTG) (i.e. steatosis), inclusive or exclusive of inflammation 
and fibrosis (namely steatohepatitis). Today, NAFLD is acknowledged all over the 
world as the leading cause of chronic liver disease (CLD). The condition brings 
about an extreme accretion of hepatocytes. It comprises a pathological field varying 
from mild, harmless steatosis to acute, critical non-alcoholic steatohepatitis, liver 
fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [4]. NAFLD is generally 
linked to insulin resistance and considered as the hepatic expression of the meta-
bolic disorder. There is a great dearth of pharmacological remedies presently for 
the treatment of NAFLD, with intentional changes in lifestyle such as weight loss 
through wholesome diet and exercise the only known means for bringing about an 
improvement in the status.
A predominant factor behind the sudden escalation of obesity is the use of 
high-fructose corn syrup in beverages. It is found that HFCS embodies >40% of 
caloric sweeteners which are included in foods and beverages. Furthermore, it is 
the primary caloric sweetener added in soft drinks in the USA, where the cases of 
obesity are steadily rising as a result. The drawback of HFCS is that the digestion, 
absorption and metabolism of fructose vary from that of glucose. Hepatic metabo-
lism of fructose supports de novo lipogenesis. Moreover, fructose does not promote 
the secretion of insulin or improvement of leptin generation. As insulin and leptin 
serve as crucial afferent signals in the control of food consumption and body 
weight, it indicates that dietary fructose may be instrumental in enlarged energy 
intake and a rise in weight. Additionally, calorically sweetened beverages are likely 
to intensify caloric consumption. These given factors suggest that the heightened 
ingestion of HFCS and its excessive intake through various liquid refreshments are 
decisive in the surge of obesity in recent times [5].
Current findings show HFCS-55 consumption to modify hepatic lipid metabo-
lism and increase the amassment of triglycerides. HFCS-55 is considered to be more 
lipogenic than sucrose, which greatly raises the danger of developing non-alcoholic 
fatty liver disease (NAFLD) and dyslipidaemia. Rats which imbibed HFCS-55 
solution were found to have the highest (P = .03) hepatic total lipid and triglyceride 
content as well as histological evidence for fat penetration [6].
Natural bioactive substances contained in fruits and vegetables inclusive of 
phenolic compounds, flavonoids and anthocyanins have generated widespread 
interest owing to their antioxidant properties. They are being steadily looked 
upon as possible remedies to combat obesity and obesity-related metabolic 
syndrome [7–10].
Mulberry is a phytonutrient-rich plant which belongs to the genus Morus and 
family Moraceae. It has been widely used as one of the conventional medicinal 
plants for centuries due to its chemical composition and pharmacological utility 
[11]. Mulberry leaves can be regarded as potential sources of phytochemi-
cal compounds with verified biological properties. The latest reports suggest 
mulberry leaves (Morus alba L.) to be a rich source of polyphenolic substances, 
including phenolic acids and flavonoids [12]. Earlier studies have revealed 
mulberry leaves to possess anticholesteremic effects [13] and cardiovascular and 
hepatoprotective properties [14, 15]. In more recent past, Song et al. [4] evalu-
ated the positive impact of mulberry fruit extract on NAFLD present in mice fed 
on a high-fat diet.
The main objective of the current study is to evaluate the beneficial effect of 
Morus latifolia leaf extract in treating HFCS-induced metabolic disorders, namely, 
dyslipidaemia and non-alcoholic fatty liver disease (NAFLD), in rat models.
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2. Materials and methods
2.1 Collection of plant material
Twigs of M. latifolia var. BC 259 were collected from the germplasm collections 
of Sericulture Department, Tamil Nadu Agricultural University, Coimbatore. Five 
to seven leaves from the apex were plucked and shade dried.
2.2 Preparation of M. latifolia leaf extract
Mulberry leaves of BC 259 were dried overnight at 90°C, and 20 g was powdered 
and extracted with 70% ethanol using the Soxhlet apparatus. The extract obtained 
was further separated with chloroform and ethyl acetate using a separating funnel. 
The polyphenolic ethyl acetate layer finally acquired was evaporated using rotary 
evaporator and was taken for its quantification of polyphenolic constituent profile 
using HPLC [16].
2.3 Identification of polyphenolic compounds by HPLC and its quantification
Phenolic constituents were determined using the HPLC method described by 
Rodriguez et al. [17]. Chromatographic conditions include separation in HPLC 
(Waters, Model: 515) fitted with photodiode array detector (Model: 2998) and ODS 
column (250 mm × 4.6 mm, 4 μm) (Hichrom, USA). Binary elution was performed 
with solvents (methanol-acetic acid-water) in the proportion of 10:2:88 and 90:2:8 
as mobile phases A and B, respectively. Measurements were made at 254 and 
280 nm. Phenolic acids were identified based on the retention time and UV spec-
trum of reference standards. Reference standards at concentrations (10–40 μg/mL) 
were injected into the HPLC-DAD system, and the calibration curves were gener-
ated. Concentrations of the compounds were calculated from peak area according to 
the generated calibration curves.
2.4 Animals
Animal studies were performed with 30 male Wistar rats weighing ~200 g 
procured from Veterinary College, Thrissur, Kerala. Animals were acclimatized at a 
temperature of 25 ± 2°C with a relative humidity of 45–55% in a 12-hour light-dark 
cycle and were fed with standard laboratory diet (rat chow diet) where water was 
given ad libitum. Rats used in the study were maintained in accordance with guide-
lines of the Institutional Animal Ethical Committee of the University. Institutional 
Animal Ethical Committee’s (IAEC) approval was obtained under experiment no. 
IAEC/KU/BT/13/02 for the present study.
2.5 Experimental design
Rats were divided into five groups with six rats each, and they were treated as 
follows: Group I, normal control rats (non-obesity control); Group II, high-fructose 
corn syrup (HFCS 20%)-induced obese rats; Group III, obese rats with standard 
drug, orlistat (120 mg/kg body weight); Group IV, obese rats with Morus latifolia 
leaf extract at dose of 250 mg/kg/day; and Group V, obese rats with Morus latifolia 
leaf extract at dose of 500 mg/kg/day. The treatment was continued orally for 
21 days (3 weeks).
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2.6 Experimental induction of obesity
All rats (four groups) except normal group were fed with HFCS (G55) dissolved 
in water to a final concentration of 20% through liquid diet in a feeding bottle with 
a capacity of 125 mL to achieve obesity, while normal control rats were fed with 
water. This diet was fed to rats of Group II to Group V for 21 days from the start of 
experiment. The obese rats (Group III) were treated with standard drug orlistat 
(200 mg/kg), and Groups IV and V were treated with Morus latifolia (BC 259) leaf 
extract with water at doses 250 and 500 mg/kg/day, respectively, for 21 days. The 
dosages were administered orally using an oral gavage.
2.7 Body weight
The body weight of the experimental animals was recorded prior to treatment 
and before sacrificing the animals according to the experimental schedule.
2.8 Biochemical analysis
At the end of the experimental period (21 days), after euthanizing the animals, 
the blood was withdrawn by cardiac puncture, and the blood samples were centri-
fuged (10,000 rpm/10 min at room temperature) to get the serum. The serum was 
transferred into the Eppendorf tubes to be stored at −20°C.
The serum collected during the post-treatment periods were analyzed with 
commercially available assay kits (ERBA Diagnostics, Mannheim, Germany) for 
determination of the levels of glucose (glucose oxidase/peroxidase (GOD/POD) 
method), lipid profile levels for high-density lipoprotein cholesterol (HDL-C), total 
cholesterol (TC) and triglycerides (TG).
LDL-C was calculated using Friedewald’s equation [18]:
  LDL − C =  [TC −  {HDL +  (TG / 5) } ] . (1)
VLDL-C levels were calculated by subtracting the sum of HDL-C and LDL-C 
concentrations from TC [19].
Liver marker enzymes such as aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and alkaline phosphatase (ALP) present in serum were 
also estimated with assay kits (ERBA Diagnostics, Mannheim, Germany). After 
the animals were euthanized by ether overdose, they were sacrificed by cervical 
dislocation.
2.9 Histopathology of liver tissue
The liver was dissected and washed with ice-cold saline immediately to 
remove the blood. The liver was immediately transferred to the fixative of 10% 
formalin. The tissues were dehydrated and embedded in paraffin wax to make it 
firm for section cutting. A section of 6 μm was made and stained in hematoxylin 
and eosin dye for microscopic observations [20].
2.10 Data analysis
Data generated was presented as mean value ± standard error mean (SEM) for 
all experimental groups. Statistical analysis was performed using SPSS version 16.0 
to conduct one-way analysis of variance (ANOVA) followed by Duncan’s Multiple 
Range test (DMRT) to find out the significant differences among the various 
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treatment groups wherever possible. Values corresponding to p < 0.05 were consid-
ered statistically significant.
3. Results
3.1 Effect of M. latifolia (var. BC 259) leaf extract on serum glucose level in HFCS-
fed rats
Table 1 represents the effect of M. latifolia leaf extract on changes in serum glu-
cose level in HFCS-fed rats. In HFCS-fed rats, there was a significant increase in blood 
glucose level (178.14 mg/dL) compared to normal control rats (89.83 mg/dL). On the 
other hand, HFCS-fed rats treated with standard orlistat reduced the blood glucose 
level to an extent of 111.87 mg/dL compared to HFCS control group (p < 0.05). Both 
the concentrations of M. latifolia leaf extract kept the glucose level under control 
compared to HFCS control group (HFCS 20%) at p < 0.01. The degree of reduction 
of the blood glucose by standard drug and M. latifolia leaf extract at 500 mg/kg was 
statistically the same.
3.2 Effect of M. latifolia leaf extract on body weight in HFCS-fed rats
The effect of M. latifolia leaf extract on body weight in HFCS-fed rats is repre-
sented in Table 2. Normal control rats registered 182.20 g body weight at the end of the 
experimental period. Contrary to normal control rats, HFCS-fed rats showed drastic 
increase in body weight (280.74 g) compared to normal control rats. HFCS-fed rats 
treated with standard drug reduced the body weight by 31.54% compared to HFCS 
control rats. Oral administration of M. latifolia leaf extract at 250 and 500 mg/kg body 
weight reduced the body weight significantly at p < 0.05 compared to HFCS control 
rats. The percentage of decrease in body weight was 25 and 29%, respectively.
3.3 Effect of M. latifolia leaf extract on lipid profile in HFCS-fed rats
The serum lipid profiles of rats at the end of the experiments are illustrated 
in Table 3. Untreated HFCS-fed rats had enhanced levels of total cholesterol and 
triglycerides and decreased levels of HDL compared to normal control rats. A sig-
nificant reduction in the levels of serum cholesterol and triglycerides was observed 
in HFCS-induced rats on administration with standard drug orlistat (200 mg/
kg) or mulberry leaf extract at 250 or 500 mg/kg compared with HFCS control 
rats (p < 0.05). It may be noted that the effect of standard drug and M. latifolia 
leaf extract at 500 mg/kg was found to be statistically the same based on DMRT. A 
Groups Glucose (mg/dL)
Normal control rats 89.83 ± 5.91a
HFCS control rats 178.14 ± 11.82d
HFCS + orlistat (120 mg/kg) 111.87 ± 7.37b
MLE (250 mg/kg) + HFCS (20%) 139.45 ± 9.23c
MLE (500 mg/kg) + HFCS (20%) 116.43 ± 7.70b
n = 6 in each group; values were presented as mean ± standard deviation. The superscript letters a–d in the column 
represent significant difference between each treatment group at 5% probability.
Table 1. 
Effect of M. latifolia leaf extract on serum glucose level in HFCS-fed rats.
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Groups TC (mg/dl) TG (mg/dl) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl)
Normal 
control rats
142.45 ± 8.85a 80.29 ± 4.42a 55.70 ± 3.32d 71.79 ± 4.20a 16.05 ± 0.97a
HFCS (20%) 
control rats
268.57 ± 16.60c 182.45 ± 10.89c 24.14 ± 1.38a 207.94 ± 12.30c 36.49 ± 2.21c
HFCS + 
orlistat 
(120 mg/kg)
148.45 ± 8.85a 82.10 ± 3.32a 53.70 ± 3.15cd 78.33 ± 4.64 a,b 16.42 ± 1.02a
MLE  
(250 mg/kg)  
+ HFCS 
(20%)
172.85 ± 10.31b 116.21 ± 6.96b 42.34 ± 2.43b 84.11.11 ± 5.01b 23.20 ± 1.46b
MLE  
(500 mg/kg)  
+ HFCS 
(20%)
150.38 ± 9.05a 85.47 ± 5.09a 51.90 ± 3.05c 81.39 ± 4.87b 17.09 ± 1.04a
n = 6 in each group; values presented are mean ± standard deviation. The superscript letters a–d in the column 
represent significant difference between each treatment group at 5% probability.
TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very-
low-density lipoprotein.
Table 3. 
Effect of M. latifolia (var. BC 259) leaf extract on levels of serum TC, TG, HDL, LDL and VLDL in normal 
and HFCS-fed rats.
Groups Final body weight (g)
Normal control rats 182.20 ± 11.06a
HFCS (20%) control rats 280.74 ± 16.60d
HFCS + orlistat (120 mg/kg) 192.17 ± 11.29a,b
MLE (250 mg/kg) + HFCS (20%) 210.54 ± 12.19c
MLE (500 mg/kg) + HFCS (20%) 198.37 ± 11.06b,c
n = 6 in each group; values presented are mean ± standard deviation. The superscript letters a–d in the column represent 
significant difference between each treatment group at 5% probability.
Table 2. 
Effect of M. latifolia leaf extract on body weight in HFCS-fed rats.
Groups ALT (U/dL) AST (U/dL) ALP (U/dL)
Normal control rats 35.45 ± 2.01a 49.54 ± 2.89a 101.94 ± 5.98a
HFCS (20%) control rats 56.77 ± 3.31e 112.31 ± 6.63e 192.76 ± 11.36d
HFCS + orlistat (120 mg/kg) 38.43 ± 2.24b 61 ± 3.6b 124.56 ± 7.34b
MLE (250 mg/kg) + HFCS (20%) 51.31 ± 3.01d 75 ± 4.44c 152.31 ± 9.00c
MLE (500 mg/kg) + HFCS (20%) 42.15 ± 2.48c 63 ± 3.73b 132.31 ± 7.81b
n = 6 in each group; values presented are mean ± standard deviation. The superscript letters a–d in the column 
represent significant difference between each treatment group at 5% probability.
AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase.
Table 4. 
Effect of M. latifolia leaf extract on levels of liver marker enzymes in HFCS-fed rats.
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significant improvement in HDL cholesterol was noticed in rats treated with stan-
dard drug or rats treated with mulberry leaf extract at 250 or 500 mg/kg.
3.4 Effect of M. latifolia leaf extract on levels of liver marker enzymes
Normal control rats registered values of 35.45 U/dL for ALT, 49.54 U/dL for AST 
and 101.94 U/dL for ALP (Table 4). Untreated HFCS-fed rats showed significantly 
increased levels of these enzymes compared to normal control rats (p < 0.05). 
When the test animals were treated either with orlistat or mulberry leaf extract at 
250 or 500 mg/kg, there was a significant reduction in the production of ALT, AST 
and ALP levels.
3.5 Histopathological evaluation of liver treated with M. latifolia leaf extract
Photomicrographs of liver tissues of normal control rats and HFCS-fed rats after 
treatment with M. latifolia are depicted in Figure 1(i–v).
4. Discussion
The consumption of fructose has seen a huge surge in the last few years, 
specifically in its fundamental form, high-fructose corn syrup (HFCS, 10–53% 
Figure 1. 
(i–v) Histopathology of the fatty liver changes in HFCS-fed rats after treatment with M. latifolia leaf extract. 
(i) Photomicrographs of liver tissues of untreated control rats showing normal hepatocytes. (ii) HFCS-fed rats 
show distorted architecture with severe fatty liver changes. (iii) Orlistat-treated rats show complete restoration 
of liver tissues with normal hepatocytes. (iv) M. latifolia (250 mg/kg)-treated rats show partial restoration 
of liver tissues with moderate fatty liver changes. (v) M. latifolia (500 mg/kg)-treated rats show maximal 
restoration of liver tissues with minimal fatty liver changes. Magnification at 40×.
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glucose and 42–90% fructose). HFCS is utilized as a sweetener in processed foods, 
baked goods, condiments, soft drinks, candy, dairy products and concentrated 
fruit juices. It is seen to be a key factor in various diseases afflicting mankind, such 
as obesity, diabetes and cancer [21]. HFCS (55), which comprises 55% fructose 
and 45% glucose, is considered to be more lipogenic than sucrose, thus posing a 
great risk in the development of non-alcoholic fatty liver disease (NAFLD) and 
dyslipidaemia.
In contrast to glucose, fructose does not facilitate the secretion of insulin or 
improvement of leptin generation. As insulin and leptin serve as crucial afferent 
signals in the control of food consumption and body weight, it indicates that dietary 
fructose may be instrumental in enlarged energy intake and a rise in weight [5]. 
In the present study, administration of HFCS effectively induced obesity in rats as 
evidenced by a significant increase in body weight possibly due to the mechanism 
mentioned above. Supplementation of mulberry leaf extract showed a tendency 
towards reduction of body weight caused by HFCS. Bocarsly and his co-workers 
[22] reported an increase in the body weight of rats consuming HFCS, and their 
results coincide with data obtained in the present study.
The metabolism of fructose in the liver results in the formation of circulating 
triglyceride in the blood stream which will eventually lead to insulin resistance 
and hyperglycaemia. In the present study, HFCS has increased the serum glucose 
level by the stated mechanism. The administration of Morus latifolia leaf extract 
decreased the serum glucose due to the positive effect of polyphenolic extract of 
mulberry on glucose homoeostasis. Song et al. [4] suggested that mulberry fruit 
ethanol extract administration significantly improved insulin sensitivity in high-
fat-fed mice.
In the present endeavor, the levels of triglycerides and total cholesterol were 
enhanced in HFCS-fed rats compared to normal control rats. The data obtained 
from the current study indicated that the model was successful in inducing 
hyperlipidaemia in rats. The latest findings show HFCS-55 intake to adversely 
affect hepatic lipid metabolism and increase the build-up of triglycerides [6]. 
Over the experimental period, treatment with M. latifolia leaf extract amelio-
rated the abnormalities in lipid profile as indicated by the significant (p < 0.05) 
decrease in serum triglycerides, cholesterol and LDL in HFCS-fed rats compared 
with untreated HFCS control rats. The degree of decrease of TC and TG levels and 
LDL induced by mulberry leaf extract (500 mg/kg body weight) suggested that 
mulberry leaf extract had a potent lipid lowering effect in hyperlipidaemia rats. 
Compared to normal control group, there was a significant decrease in HDL in 
HFCS control rats. In this study, we found that administration of M. latifolia leaf 
extract raised HDL levels in HFCS-fed animals. This rise in HDL may be the result 
of antiobesity effect caused by the inhibition of dyslipidaemia, hepatosteatosis 
and oxidative stress in obese rats [23, 24].
Yang et al. [25] found that administration of freeze-dried mulberry fruit 
powder resulted in a significant decrease in the serum levels of TC, TG and LDL 
and the hepatic levels of TG and TC and an increase in HDL in high-fat-fed rats. 
Chang et al. [26] illustrated from their studies that mulberry leaf polyphenol 
extract (MLPE) improves obesity by inducing adipocyte apoptosis and inhibit-
ing pre-adipocyte differentiation and hepatic lipogenesis. They found quercetin 
and caffeic acids to be the main ingredients of MLPE which inhibit the dif-
ferentiation of 3T3-L1 pre-adipocytes. Orally administering MLPE significantly 
reduced body weight gain and lipid accumulation in the liver and serum/hepatic 
triglyceride and total cholesterol levels compared with those in high-fat diet 
(HFD) group. Song et al. [4] demonstrated the effect of ethanolic extract of 
mulberry fruit in reducing HFD-induced obesity and hepatic steatosis in mice. 
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The protective effect of mulberry ethanol extract was associated with the induc-
tion of fatty acid oxidation and decreased fatty acid and cholesterol biosynthe-
sis. Our results are also at par? with Andallu et al. [27]. Results obtained from 
the present study substantiated the earlier findings as well [13, 28, 29].
From the current study, the major polyphenolic compounds identified in  
M. latifolia were chlorogenic acid, caffeic acid, coumaric acid, rutin and quercetin. 
Studies have indicated that rutin could significantly reduce the levels of oleic 
acid-induced lipid accumulation through reducing lipogenesis and oxidative stress 
in hepatic carcinoma cells [30]. Previous studies have also shown that rutin may 
possess antiobesity effects in decreasing body weight, improving serum lipid pro-
files and regulating lipid metabolism [31]. Similarly, quercetin has been reported 
to have antiobesity effects in promoting hepatic lipolysis [32], inhibiting adipocyte 
differentiation, suppressing adipocytes adipogenesis, decreasing body weight [33] 
and improving serum lipid profiles [28]. Taher et al. [34] reported that caffeic acid 
isolated from Arctium lappa has antihyperlipidaemic effect in hyperlipidaemic rat 
models. Caffeic acid was reported to have antiobesity effects in decreasing body 
weight [35], attenuating fatty liver [36], promoting hepatic lipolysis [37] and 
regulating lipid metabolism [35].
Antihyperlipidaemic activity of p-coumaric acid in diabetic rats was also 
reported [38]. Based on these reports, we infer that crude plant extract contributing 
to the antiobesity effect would be due to the multiple bioactive polyphenolic com-
pounds present in M. latifolia which had played a major beneficial role in treating 
the abnormalities in lipid metabolism.
In the present study, the increased level of liver marker enzymes (AST, ALT and 
ALP) was reduced and attained near-normal values when the animal groups were 
administrated with mulberry leaf extract. Similar results were obtained by Song and 
his co-workers [4] who reported that serum ALT and AST levels were reduced when the 
rats were fed with mulberry leaf ethanolic extract. High-fructose diets have induced 
fatty liver in rats [39]. NAFLD is characterized by lipid deposition in the liver, that is, 
steatosis [40]. Meli et al. [41] established that HFD induced hepatic steatosis in mice 
and rats. In addition, Chien et al. [42] reported that HFD feeding significantly increased 
liver weight, hepatic triglycerides and total cholesterol accumulation and hepatic 
vacuoles.
In this study, histological analysis of livers revealed that mulberry leaf extract 
administration reduced attenuated hepatic fat accumulation, even causing a regen-
eration of liver tissues. This has also been corroborated with reduced triglycerides 
and total cholesterols and serum ALT and AST levels in the mulberry leaf extract 
administrated group of rats. Identical results were reported earlier by Song et al. [4] 
with special reference to histopathological studies.
In conclusion, the results established that mulberry leaf extract ameliora-
tion improved hepatic steatosis which is due to lowered serum TC and TG lev-
els. The study further suggested that mulberry leaf extract could be a natural 
dietary choice in the management of metabolic disorders such as obesity and 
fatty liver disease probably due to the presence of bioactive constituents, and 
it provides valuable input in adding to the current knowledge of the human 
nutrition and health.
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